Companies / Nuvation Bio Inc. / Activity
Activity — Nuvation Bio Inc.
25 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Wentworth Kerry Executive | Sell | Class A Common Stock | $903.6K | -200K -79.05% | 53,000 0.02% of shares | medium |
| Jun 23, 2026 | Wentworth Kerry Executive | Sell | Class A Common Stock | $379.2K | -63K -54.31% | 53,000 0.02% of shares | medium |
| Apr 6, 2026 | Wentworth Kerry Executive | Exercise | Class A Common Stock | $194.0K | +100K +65.36% | 253,000 0.07% of shares | low |
| Apr 6, 2026 | Wentworth Kerry Executive | Exercise | Class A Common Stock | $187.0K | +100K +188.68% | 153,000 0.04% of shares | low |
| Jun 23, 2026 | Wentworth Kerry Executive | Exercise | Class A Common Stock | $184.6K | +63K +118.87% | 116,000 0.03% of shares | low |
| Apr 17, 2026 | Wentworth Kerry Executive | Sell | Class A Common Stock | $184.3K | -37K -40.95% | 53,000 0.02% of shares | medium |
| Apr 17, 2026 | Wentworth Kerry Executive | Exercise | Class A Common Stock | $107.7K | +37K +69.34% | 89,750 0.03% of shares | low |
| Feb 27, 2026 | Makunje Moses Executive | Grant | Class A Common Stock | $0 | +51K +292.13% | 68,137 0.02% of shares | low |
| Jun 23, 2026 | Wentworth Kerry Executive | Exercise | Stock Option (Right to Buy) | — | -63K -29.27% | 152,250 0.04% of shares | low |
| Apr 17, 2026 | Wentworth Kerry Executive | Exercise | Stock Option (Right to Buy) | — | -37K -14.58% | 215,250 0.06% of shares | low |
| Apr 6, 2026 | Wentworth Kerry Executive | Exercise | Stock Option (Right to Buy) | — | -100K -25.00% | 300,000 0.09% of shares | low |
| Apr 6, 2026 | Wentworth Kerry Executive | Exercise | Stock Option (Right to Buy) | — | -100K -20.00% | 400,000 0.11% of shares | low |
| May 21, 2026 | Vernon W Anthony Director | Grant | Stock Option (Right to Buy) | — | +123K | 123,397 0.04% of shares | low |
| May 21, 2026 | Blickenstaff Kim D Director | Grant | Stock Option (Right to Buy) | — | +123K | 123,397 0.04% of shares | low |
| May 21, 2026 | Falberg Kathryn E Director | Grant | Stock Option (Right to Buy) | — | +123K | 123,397 0.04% of shares | low |
| Feb 27, 2026 | Sauvage Philippe Executive | Grant | Stock Option (Right to Buy) | — | +748K | 748,130 0.21% of shares | low |
| Feb 27, 2026 | Sjogren Colleen Executive | Grant | Stock Option (Right to Buy) | — | +748K | 748,130 0.21% of shares | low |
| Feb 27, 2026 | Makunje Moses Executive | Grant | Stock Option (Right to Buy) | — | +224K | 224,439 0.06% of shares | low |
| Feb 27, 2026 | Liu Dongfang Executive | Grant | Stock Option (Right to Buy) | — | +748K | 748,130 0.21% of shares | low |
| Feb 27, 2026 | Hanley David C. Executive | Grant | Stock Option (Right to Buy) | — | +748K | 748,130 0.21% of shares | low |
| Feb 27, 2026 | Markel Stacy Executive | Grant | Stock Option (Right to Buy) | — | +748K | 748,130 0.21% of shares | low |
| Feb 27, 2026 | Hattersley Gary Executive | Grant | Stock Option (Right to Buy) | — | +748K | 748,130 0.21% of shares | low |
| Feb 27, 2026 | Cui Xiangmin Director | Grant | Stock Option (Right to Buy) | — | +75K | 74,813 0.02% of shares | low |
| Feb 27, 2026 | Wentworth Kerry Executive | Grant | Stock Option (Right to Buy) | — | +748K | 748,130 0.21% of shares | low |
| Feb 27, 2026 | Hung David CEO | Grant | Stock Option (Right to Buy) | — | +2.0M | 1,995,012 0.57% of shares | low |